|
Market Closed -
NYSE
00:00:02 28/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 40.39 USD | +1.10% |
|
-1.13% | +41.17% |
| 10-27 | Teva Pharmaceutical Industries Unit Buys Rights to BXCL501 From BioXcel Therapeutics | MT |
| 10-26 | Tel Aviv Stock Exchange: the paradox of a market that is resisting, despite the war |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Other Pharmaceuticals | +1.10% | -1.13% | +41.17% | +118.32% | +311.72% | 47.07B |  |  | |
Select your edition
All financial news and data tailored to specific country editions
